Identification of evolutionarily stable functional and immunogenic sites across the SARS-CoV-2 proteome and greater coronavirus family
Open Access
- 27 May 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 37 (22) , 4033-4040
Abstract
Since the first recognized case of COVID-19, more than 100 million people have been infected worldwide. Global efforts in drug and vaccine development to fight the disease have yielded vaccines and drug candidates to cure COVID-19. However, the spread of SARS-CoV-2 variants threatens the continued efficacy of these treatments. In order to address this, we interrogate the evolutionary history of the entire SARS-CoV-2 proteome to identify evolutionarily conserved functional sites that can inform the search for treatments with broader coverage across the coronavirus family. Combining coronavirus family sequence information with the mutations observed in the current COVID-19 outbreak, we systematically and comprehensively define evolutionarily stable sites that may provide useful drug and vaccine targets and which are less likely to be compromised by the emergence of new virus strains. Several experimentally validated effective drugs interact with these proposed target sites. In addition, the same evolutionary information can prioritize cross reactive antigens that are useful in directing multi-epitope vaccine strategies to illicit broadly neutralizing immune responses to the betacoronavirus family. Although the results are focused on SARS-CoV-2, these approaches stem from evolutionary principles that are agnostic to the organism or infective agent. The results of this work are made interactively available at http://cov.lichtargelab.org. Supplementary data are available at Bioinformatics online.Keywords
All Related Versions
Funding Information
- Office of the Director of National Intelligence
- Intelligence Advanced Research Projects Activity (BAA-17-01, #2019-19071900001)
- National Science Foundation (DBI-2032904)
- Oskar Fischer Foundation
- National Institutes of Health (GM079656, GM066099, AG061105)
This publication has 64 references indexed in Scilit:
- Prediction and experimental validation of enzyme substrate specificity in protein structuresProceedings of the National Academy of Sciences, 2013
- Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS ModelThe Journal of Infectious Diseases, 2011
- Sequence and structure continuity of evolutionary importance improves protein functional site discovery and annotationProtein Science, 2010
- Evolution-guided discovery and recoding of allosteric pathway specificity determinants in psychoactive bioamine receptorsProceedings of the National Academy of Sciences, 2010
- Characterization of a Highly Conserved Domain within the Severe Acute Respiratory Syndrome Coronavirus Spike Protein S2 Domain with Characteristics of a Viral Fusion PeptideJournal of Virology, 2009
- Structure of the SARS Coronavirus Nucleocapsid Protein RNA-binding Dimerization Domain Suggests a Mechanism for Helical Packaging of Viral RNAJournal of Molecular Biology, 2007
- Ribonucleocapsid Formation of Severe Acute Respiratory Syndrome Coronavirus through Molecular Action of the N-Terminal Domain of N ProteinJournal of Virology, 2007
- Evolutionary Trace-based Peptides Identify a Novel Asymmetric Interaction That Mediates Oligomerization in Nuclear ReceptorsJournal of Biological Chemistry, 2005
- A Family of Evolution–Entropy Hybrid Methods for Ranking Protein Residues by ImportanceJournal of Molecular Biology, 2004
- An Evolutionary Trace Method Defines Binding Surfaces Common to Protein FamiliesJournal of Molecular Biology, 1996